Misoprostol is used in pregnancy for several distinct purposes: inducing labor, managing miscarriage, medication abortion, and treating dangerous bleeding after delivery. It works by softening and opening the cervix while triggering uterine contractions, making it one of the most versatile medications in obstetric care. Originally developed to treat stomach ulcers, most of its pregnancy-related uses are technically off-label, though they are well-established in medical practice worldwide.
How Misoprostol Works on the Uterus
Misoprostol is a synthetic version of a natural hormone-like substance called prostaglandin E1. Prostaglandins play a key role in labor and delivery by preparing the cervix and stimulating the uterine muscles. When misoprostol enters the body, it mimics these natural signals, producing two main effects: it softens and dilates the cervix, and it causes the uterus to contract. Both effects are dose-dependent, meaning higher amounts produce stronger responses.
These two actions together make misoprostol useful across a wide range of situations in pregnancy, from helping labor get started at full term to completing a miscarriage that the body hasn’t resolved on its own.
Inducing Labor
When a pregnancy needs to be delivered but labor hasn’t started naturally, the cervix is often firm and closed. Misoprostol helps ripen the cervix (making it soft and ready to dilate) and then triggers contractions to move labor along. This is especially useful for women whose cervix shows very little readiness for labor.
In a study of women with extremely unfavorable cervical conditions, roughly 90% delivered within 48 hours of receiving a misoprostol vaginal insert. For women past 41 weeks, that number climbed to nearly 96%. Vaginal delivery rates ranged from about 55% to 61% depending on gestational age, with the remainder requiring cesarean delivery for other reasons. These results make misoprostol one of the more effective options for getting labor started when the cervix isn’t cooperating.
Medication Abortion
Misoprostol is a core part of the standard medication abortion protocol. The most common approach pairs it with mifepristone: mifepristone is taken first to block the hormone progesterone that sustains a pregnancy, and then misoprostol is taken one to two days later to cause the uterus to contract and expel the pregnancy tissue.
This combination is highly effective. Up to nine weeks of pregnancy, success rates range from 95% to 98%. After nine weeks, effectiveness dips slightly with a single dose, but giving a second dose a few hours later brings success rates back above 98% through about 11 weeks. Between 10 and 13 weeks, roughly 4% to 8% of patients end up needing a surgical procedure to complete the process. Overall, the combination carries complication rates of just 1% to 3%.
When mifepristone isn’t available, misoprostol can be used on its own, though success rates are somewhat lower. The FDA has approved the mifepristone-misoprostol combination specifically for medication abortion, while the misoprostol-only approach remains an off-label but widely recommended alternative.
Managing Miscarriage
When a pregnancy has stopped developing but the body hasn’t expelled the tissue on its own (sometimes called a missed miscarriage), misoprostol offers a nonsurgical option. Rather than waiting or scheduling a procedure, many women can take misoprostol vaginally to help the uterus clear the pregnancy tissue.
A major trial published in the New England Journal of Medicine compared this approach to surgical management in 652 women with first-trimester pregnancy loss. Among those given misoprostol, 71% had complete expulsion within three days, and 84% by day eight. About 16% ultimately needed a surgical procedure within 30 days, compared to just 3% of women who had surgery as their initial treatment. For many women, the ability to manage a miscarriage at home without anesthesia or a procedure makes misoprostol the preferred choice, even though the success rate is lower than surgery.
Preventing Dangerous Bleeding After Delivery
Postpartum hemorrhage, or severe bleeding after childbirth, is a leading cause of maternal death globally. Misoprostol helps prevent and treat it by causing the uterus to contract firmly after delivery, which compresses the blood vessels at the site where the placenta was attached.
This use is particularly important in low-resource settings where injectable medications or refrigeration may not be available. Misoprostol tablets are inexpensive, stable at room temperature, and don’t require trained personnel to administer through an IV. The evidence supports a 600-microgram oral dose for prevention and an 800-microgram dose placed under the tongue for active treatment of hemorrhage already underway.
How Different Routes of Administration Compare
Misoprostol can be taken orally (swallowed), vaginally, sublingually (under the tongue), or buccally (between the cheek and gum). Each route produces a different pattern of absorption, and doctors choose the route based on the clinical situation.
Placed under the tongue, misoprostol reaches its peak blood levels in about 26 minutes and achieves the highest concentration of any route. Swallowed, it peaks at a similar speed but at about half the concentration. Vaginal administration is slower, taking roughly 70 to 75 minutes to peak, but the drug’s effects linger longer, with measurable levels persisting beyond six hours. This sustained effect makes the vaginal route well-suited for labor induction, where a steady, prolonged action on the cervix is desirable. The sublingual route works well when a fast response is needed, such as during postpartum hemorrhage.
Common Side Effects
Because misoprostol stimulates smooth muscle throughout the body, not just in the uterus, side effects are common and predictable. The most frequent are shivering and fever. In clinical data, about 43% of women experienced shivering and 34% developed a fever after receiving misoprostol. Nausea, vomiting, diarrhea, and cramping also occur, though less frequently.
Fever typically follows a recognizable pattern: a sharp rise within the first hour, a peak one to two hours after the dose, and a gradual return to normal over the next several hours. Even high fevers (above 40°C or 104°F) generally last less than two hours at their peak and resolve within about six hours. Severe shivering, described as uncontrollable shaking, is more common in women who develop the highest temperatures but remains relatively uncommon overall. These side effects are transient and resolve on their own, usually within 12 hours.
Who Should Not Use Misoprostol
The most significant safety concern involves women with a prior cesarean section or other uterine surgery. Misoprostol is not recommended for labor induction in women with a uterine scar because the drug’s contractions can, in rare cases, cause the scar to rupture. This risk is highest in late pregnancy, when the uterus is most stretched and the contractions are strongest. Case reports of uterine rupture from misoprostol have almost exclusively involved women with a prior cesarean or other uterine anomalies.
In the first trimester, the risk of scar disruption is much lower because the uterus is smaller and less pressure builds during contractions. Still, providers exercise caution. For miscarriage management or abortion in women with prior uterine surgery, the decision involves weighing a small but real risk against the benefits of avoiding a surgical procedure.